InspireMD Financials

NSPR Stock  USD 2.76  0.01  0.36%   
Based on the measurements of operating efficiency obtained from InspireMD's historical financial statements, InspireMD is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February. At this time, InspireMD's Common Stock is relatively stable compared to the past year. As of 01/12/2025, Short and Long Term Debt Total is likely to grow to about 2.7 M, while Total Current Liabilities is likely to drop slightly above 4.2 M. Key indicators impacting InspireMD's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio6.936.6
Sufficiently Up
Slightly volatile
The essential information of the day-to-day investment outlook for InspireMD includes many different criteria found on its balance sheet. An individual investor should monitor InspireMD's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in InspireMD.

Net Income

(18.82 Million)

-7.2M-10.0M-10.5M-14.9M-18.5M-19.9M-17.9M-18.8M100%
  

InspireMD Earnings Geography

InspireMD Stock Summary

InspireMD competes with Bone Biologics, Tivic Health, Bluejay Diagnostics, Vivos Therapeutics, and Rapid Micro. InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Inspiremd operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS45779A8466
CUSIP45779A846 45779A309 45779A853 45779A804 45779A861 45779A507 45779A101
LocationIsrael
Business Address4 Menorat Hamaor
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.inspiremd.com
Phone972 3 6917691
CurrencyUSD - US Dollar

InspireMD Key Financial Ratios

InspireMD Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets17.8M39.7M24.7M47.6M54.8M57.5M
Other Current Liab3.1M3.0M4.0M4.5M5.2M2.7M
Net Debt(11.6M)(10.8M)(3.0M)(9.6M)(8.7M)(8.2M)
Retained Earnings(168.2M)(183.1M)(201.6M)(221.5M)(199.4M)(189.4M)
Cash12.6M12.0M4.6M9.6M11.1M7.6M
Total Liab5.6M6.2M7.3M8.1M9.4M6.9M
Total Current Assets15.3M37.1M21.3M44.2M50.8M53.3M
Net Receivables945K1.4M1.2M1.8M1.6M1.0M
Inventory1.4M1.1M1.6M2.1M1.9M1.2M
Short Term Debt400K420K419K557K501.3K945.1K
Other Liab729K910K1.1M995K1.1M738.6K
Accounts Payable236K893K659K939K845.1K570.7K
Other Assets586K725K905K856K984.4K506K
Other Current Assets334K522K655K3.0M3.5M3.7M
Net Tangible Assets5.4M12.2M33.5M17.4M20.0M21.0M
Net Invested Capital12.2M33.5M17.4M39.5M45.4M47.7M

InspireMD Key Income Statement Accounts

The reason investors look at the income statement is to determine what InspireMD's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Interest Expense42K160K157K28K25.2K23.9K
Operating Income(10.4M)(14.7M)(18.7M)(21.1M)(19.0M)(18.1M)
Ebit(10.4M)(14.7M)(18.7M)(21.1M)(19.0M)(20.0M)
Ebitda(10.2M)(14.6M)(18.5M)(20.9M)(18.8M)(17.9M)
Income Before Tax(10.5M)(14.9M)(18.5M)(19.9M)(17.9M)(18.8M)
Net Income(10.5M)(14.9M)(18.5M)(19.9M)(17.9M)(18.8M)
Total Revenue2.5M4.5M5.2M6.2M5.6M3.3M
Gross Profit83K754K1.1M1.8M1.6M1.0M
Research Development2.2M5.2M7.8M8.0M9.2M9.6M
Cost Of Revenue2.4M3.7M4.1M4.4M5.1M3.1M
Net Interest Income(160K)(157K)250K1.3M1.5M1.6M

InspireMD Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash7.1M(641K)(7.4M)5.0M4.5M4.7M
Free Cash Flow(9.2M)(13.6M)(16.0M)(16.8M)(15.1M)(14.3M)
Capital Expenditures88K344K473K381K438.2K460.1K
Net Income(10.5M)(14.9M)(18.5M)(19.9M)(17.9M)(18.8M)
End Period Cash Flow12.6M12.0M4.6M9.6M11.1M7.2M
Change To Inventory(179K)272K(478K)(485K)(436.5K)(414.7K)
Depreciation151K161K188K232K266.8K190.3K
Other Non Cash Items(4K)(28K)14K(381K)(342.9K)(325.8K)
Investments(187K)(22M)8.4M(16.1M)(14.5M)(13.8M)

InspireMD Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining InspireMD's current stock value. Our valuation model uses many indicators to compare InspireMD value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InspireMD competition to find correlations between indicators driving InspireMD's intrinsic value. More Info.
JavaScript chart by amCharts 3.21.15SRDXLNSRSGHTSSKNTLISAIMDNSPR -0.40-0.35-0.30-0.25-0.20-0.15-0.10-0.050 -0.8-0.7-0.6-0.5-0.4-0.3-0.2-0.10
InspireMD is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, InspireMD's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value InspireMD by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

InspireMD Systematic Risk

InspireMD's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. InspireMD volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on InspireMD correlated with the market. If Beta is less than 0 InspireMD generally moves in the opposite direction as compared to the market. If InspireMD Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one InspireMD is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of InspireMD is generally in the same direction as the market. If Beta > 1 InspireMD moves generally in the same direction as, but more than the movement of the benchmark.
JavaScript chart by amCharts 3.21.15OctNovDecDecDec 09Dec 16Dec 23Dec 30Jan2.72.82.93.03.1 100K200K300K400K500K600K -0.10-0.0500.050.10 42K42.5K43K43.5K44K44.5K45K Show all
JavaScript chart by amCharts 3.21.15InspireMD Volume InspireMD Closing Prices Dow Jones Industrial Closing Prices - Benchmark InspireMD Beta

InspireMD Thematic Clasifications

InspireMD is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Medical EquipmentView
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in InspireMD Stock are looking for potential investment opportunities by analyzing not only static indicators but also various InspireMD's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of InspireMD growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0497

0.0000.0000.0000.0050.0030.0080.021-0.0230.05260.04730.0497100%
At this time, InspireMD's Price Earnings To Growth Ratio is relatively stable compared to the past year.

InspireMD January 12, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of InspireMD help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of InspireMD. We use our internally-developed statistical techniques to arrive at the intrinsic value of InspireMD based on widely used predictive technical indicators. In general, we focus on analyzing InspireMD Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InspireMD's daily price indicators and compare them against related drivers.

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.

Trending Assets

LNSR
LENSAR Inc
8.25  -0.1  -1.2 
AZYO
Aziyo Biologics
2.44  0.00  0.00 
SRDX
SurModics
38.44  -0.56  -1.44 
BJDX
Bluejay Diagnostics
3.65  0.14  3.99